Dr. Richard “Rick" Winneker discussed advice that he would provide to patients faced with a myeloproliferative neoplasm ...

Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...

The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and ...

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical ...

Advances in robotic-assisted surgery are redefining the approach to thyroid and parotid salivary gland conditions, offering solutions that prioritize precision, minimal invasiveness, and ...